4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-011756
President and CEO sold 27,750 shares at an average $31.11 ($863,378)
From the SEC's structured data for this filing
Trades in this filing
SCANGOS GEORGE A · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-17 | Sale : show line 1 in the form | −10,024 | $31.93 | $320,074 | 130,715 | D |
| 2022-02-18 | Sale : show line 2 in the form | −17,726 | $30.65 | $543,304 | 112,989 | D |
| Open-market sales · 27,750 sh · avg $31.11 · $863,378 | ||||||
Loading xslF345X03/doc4.xml…